Business Description
IMAC Holdings Inc. operates through its subsidiary Ignite Proteomics LLC to deliver advanced cancer treatment solutions across the United States. The company uses protein analysis technology to help doctors make more informed treatment decisions and to support the development of new cancer drugs. Founded in 2000 and headquartered in Franklin, Tennessee, IMAC Holdings serves both clinical and pharmaceutical clients seeking deeper insight into how proteins behave in cancer patients.
